Frontiers
We support the next generation of scientists
About
The ESACT Frontiers Program (EFP) is an initiative within the European Society for the Advancement of Cell Technology focused on promoting career progression and active engagement of young generations to ESACT and to the field of Animal Cell Technology (ACT). With this, the next generation of ESACT scientists gets a platform to influence the development of the society and can give the young generation of scientists a voice in our community.
The EFP was founded in 2014 and the group is constituted by early career scientists from academic, governmental and private institutions.
Mission statement
Provide opportunities for early career scientists to personally and professionally develop whilst actively engaging in, influencing and developing the advancing cell technology community
ESACT Frontiers will actively encourage the participation and interaction between Master, PhD students and post-doctoral fellow members of the Society with the goal of supporting training and career development.
The EFP will also launch initiatives to challenge early career researchers to promote academia-industry interaction and to support innovative and unconventional ideas helping to open ESACT to future trends of science and technology.
If you have exciting and innovative ideas, get involved in EFP activities!
Contact any Frontiers member and help to build the next generation of Animal Cell Technology researchers and professionals.
Your suggestions and ideas are very welcome. We will do our best to accommodate them in our next initiatives.
Current EFP Members
Laetitia Aurand
KBI Biopharma Geneva, Switzerland
James Budge
University of Kent, UK
Valentine Chevallier
UCB Brussels, Belgium
Hirra Hussain
CPI darlington, UK
Nicolas Marx
BOKU Vienna, Austria
Alexander Nikolay
Miltenyi Biotec Germany
Nikolas Zeh
Asimov Boston, USA
placeholder
Previous EFP Members
- Claire Pearce (2019 – 2024), Independent (Boston, USA)
- Nuša Pristovšek (2019 – 2024), Novo Nordisk A/S (Måløv, Denmark)
- Bernhard Sissolak (2019 – 2024), Bilfinger Industrietechnik Salzburg (Vienna, Austria)
- Paulo Fernandes (2017 – 2022), Orchard Therapeutics (London, UK)
- Verena Lohr (2017 – 2022), Sanofi (Frankfurt, Germany)
- Igor Slivac (2017 – 2022), University of Zagreb (Zagreb, Croatia)
- Ricardo Valdés-Bango (2017 – 2022), Curell Suñol – IP Attorneys (Barcelona, Spain)
- Emma Petiot (2014 – 2019), CPE-Lyon Engineer School (Lyon, France)
- Simon Ausländer (2014 – 2019), Roche (Penzberg, Germany)
- Ana Filipa Rodrigues (2014 – 2019), iBET (Oeiras, Portugal)
- Christopher Sellick (2014 – 2019), Kymab (Cambridge, UK)
- Mercedes Segura (2014 – 2017), ElevateBio (Cambridge, MA, USA)
- Markus Heine (2014 – 2015) Fraunhofer Institute for Toxicology
and Experimental Medicine (Germany)